Iatrogenic Immunosuppression and Cutaneous Malignancy

Document Type

Article

Publication Title

Clinics in Dermatology

Abstract

Patients with autoimmune and inflammatory conditions often receive long-term immunosuppressive therapy. Some of the largest patient populations with iatrogenic immunosuppression include patients who have received solid-organ transplants or who have rheumatoid arthritis or psoriasis. Although treatments improve patient outcomes, individuals with immunosuppression subsequently may have an increased risk of skin cancer, including squamous cell carcinoma, basal cell carcinoma, and malignant melanoma.

DOI

10.1016/j.clindermatol.2011.08.009

Publication Date

11-2011

ISSN

1879-1131

Link to Full Text

Share

COinS